http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102421013-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-41 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41 |
| filingDate | 2017-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102421013-B1 |
| titleOfInvention | Use of carbamate compound for prevention or treatment of trigeminal neuralgia |
| abstract | The present invention relates to a carbamate compound of Formula 1, or a pharmaceutically acceptable salt, solvate or hydrate thereof; And to a pharmaceutical composition for preventing or treating trigeminal neuralgia comprising a pharmaceutically acceptable carrier, the pharmaceutical composition according to the present invention can effectively prevent or treat trigeminal neuralgia: [Formula 1] In Formula 1, R 1 , R 2 , A 1 and A 2 are as defined in the specification. |
| priorityDate | 2016-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 184.